BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hunt JJ, Ballard JD. Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev. 2013;77:567-581. [PMID: 24296572 DOI: 10.1128/mmbr.00017-13] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Isidro J, Menezes J, Serrano M, Borges V, Paixão P, Mimoso M, Martins F, Toscano C, Santos A, Henriques AO, Oleastro M. Genomic Study of a Clostridium difficile Multidrug Resistant Outbreak-Related Clone Reveals Novel Determinants of Resistance. Front Microbiol 2018;9:2994. [PMID: 30574133 DOI: 10.3389/fmicb.2018.02994] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
2 Simecka JW, Fulda KG, Pulse M, Lee JH, Vitucci J, Nguyen P, Taylor P, Filipetto F, Espinoza AM, Sharma S. Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region. PLoS One 2019;14:e0220646. [PMID: 31415582 DOI: 10.1371/journal.pone.0220646] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Koon HW, Su B, Xu C, Mussatto CC, Tran DH, Lee EC, Ortiz C, Wang J, Lee JE, Ho S, Chen X, Kelly CP, Pothoulakis C. Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters. Am J Physiol Gastrointest Liver Physiol. 2016;311:G610-G623. [PMID: 27514478 DOI: 10.1152/ajpgi.00150.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
4 Rashid SJ, Barylski J, Hargreaves KR, Millard AA, Vinner GK, Clokie MR. Two Novel Myoviruses from the North of Iraq Reveal Insights into Clostridium difficile Phage Diversity and Biology. Viruses 2016;8:E310. [PMID: 27854339 DOI: 10.3390/v8110310] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
5 Beer LA, Tatge H, Schneider C, Ruschig M, Hust M, Barton J, Thiemann S, Fühner V, Russo G, Gerhard R. The Binary Toxin CDT of Clostridium difficile as a Tool for Intracellular Delivery of Bacterial Glucosyltransferase Domains. Toxins (Basel) 2018;10:E225. [PMID: 29865182 DOI: 10.3390/toxins10060225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 Meehan AM, Tariq R, Khanna S. Challenges in management of recurrent and refractory Clostridium difficile infection. World J Clin Infect Dis 2016; 6(3): 28-36 [DOI: 10.5495/wjcid.v6.i3.28] [Reference Citation Analysis]
7 Chung SY, Schöttelndreier D, Tatge H, Fühner V, Hust M, Beer LA, Gerhard R. The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding. Front Microbiol 2018;9:2314. [PMID: 30416488 DOI: 10.3389/fmicb.2018.02314] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
8 Chen P, Tao L, Wang T, Zhang J, He A, Lam KH, Liu Z, He X, Perry K, Dong M, Jin R. Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. Science 2018;360:664-9. [PMID: 29748286 DOI: 10.1126/science.aar1999] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 11.5] [Reference Citation Analysis]
9 Vitucci JC, Pulse M, Tabor-Simecka L, Simecka J. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models. BMC Microbiol 2020;20:27. [PMID: 32024477 DOI: 10.1186/s12866-020-1710-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen R, Feng Y, Wang X, Yang J, Zhang X, Lü X, Zong Z. Whole genome sequences of three Clade 3 Clostridium difficile strains carrying binary toxin genes in China. Sci Rep 2017;7:43555. [PMID: 28262711 DOI: 10.1038/srep43555] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
11 Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B, Ling L, Leiner I, Pamer EG. Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. Cell Host Microbe 2015;18:27-37. [PMID: 26159718 DOI: 10.1016/j.chom.2015.06.011] [Cited by in Crossref: 162] [Cited by in F6Publishing: 155] [Article Influence: 27.0] [Reference Citation Analysis]
12 Tao L, Tian S, Zhang J, Liu Z, Robinson-McCarthy L, Miyashita SI, Breault DT, Gerhard R, Oottamasathien S, Whelan SPJ, Dong M. Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells. Nat Microbiol 2019;4:1760-9. [PMID: 31160825 DOI: 10.1038/s41564-019-0464-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
13 Peng JW, Yuan H, Tan XS. Crystal structure of the multiple antibiotic resistance regulator MarR from Clostridium difficile. Acta Crystallogr F Struct Biol Commun 2017;73:363-8. [PMID: 28580925 DOI: 10.1107/S2053230X1700766X] [Reference Citation Analysis]
14 Mitachi K, Yun HG, Kurosu SM, Eslamimehr S, Lemieux MR, Klaić L, Clemons WM Jr, Kurosu M. Novel FR-900493 Analogues That Inhibit the Outgrowth of Clostridium difficile Spores. ACS Omega 2018;3:1726-39. [PMID: 29503973 DOI: 10.1021/acsomega.7b01740] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
15 Larabee JL, Bland SJ, Hunt JJ, Ballard JD. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB. mBio 2017;8:e00503-17. [PMID: 28512094 DOI: 10.1128/mBio.00503-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
16 Deng L, Tay H, Peng G, Lee JWJ, Tan KSW. Prevalence and molecular subtyping of Blastocystis in patients with Clostridium difficile infection, Singapore. Parasit Vectors 2021;14:277. [PMID: 34030712 DOI: 10.1186/s13071-021-04749-8] [Reference Citation Analysis]
17 Erickson SL, Alston L, Nieves K, Chang TKH, Mani S, Flannigan KL, Hirota SA. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins. FASEB J 2020;34:2198-212. [PMID: 31907988 DOI: 10.1096/fj.201902083RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Muñoz M, Ríos-Chaparro DI, Herrera G, Soto-De Leon SC, Birchenall C, Pinilla D, Pardo-Oviedo JM, Josa DF, Patarroyo MA, Ramírez JD. New Insights into Clostridium difficile (CD) Infection in Latin America: Novel Description of Toxigenic Profiles of Diarrhea-Associated to CD in Bogotá, Colombia. Front Microbiol 2018;9:74. [PMID: 29441053 DOI: 10.3389/fmicb.2018.00074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Mani S, Rybicki L, Jagadeesh D, Mossad SB. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant 2016;51:713-7. [PMID: 26726944 DOI: 10.1038/bmt.2015.311] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
20 Steglich M, Nitsche A, von Müller L, Herrmann M, Kohl TA, Niemann S, Nübel U. Tracing the Spread of Clostridium difficile Ribotype 027 in Germany Based on Bacterial Genome Sequences. PLoS One 2015;10:e0139811. [PMID: 26444881 DOI: 10.1371/journal.pone.0139811] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
21 Dembek M, Kelly A, Barwinska-Sendra A, Tarrant E, Stanley WA, Vollmer D, Biboy J, Gray J, Vollmer W, Salgado PS. Peptidoglycan degradation machinery in Clostridium difficile forespore engulfment. Mol Microbiol 2018;110:390-410. [PMID: 30066424 DOI: 10.1111/mmi.14091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
22 García-Fernández S, Frentrup M, Steglich M, Gonzaga A, Cobo M, López-Fresneña N, Cobo J, Morosini MI, Cantón R, Del Campo R, Nübel U. Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario. Sci Rep 2019;9:6959. [PMID: 31061423 DOI: 10.1038/s41598-019-43464-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Su YH, Warren CA, Guerrant RL, Swami NS. Dielectrophoretic monitoring and interstrain separation of intact Clostridium difficile based on their S(Surface)-layers. Anal Chem 2014;86:10855-63. [PMID: 25343746 DOI: 10.1021/ac5029837] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
24 Wang JJ, Liu CC, Fan Y, Xu ZJ, Zhang YS, Yang XB, Wang JS, Zhang ZY. Clinical features of opportunistic infections in ulcerative colitis patients. Shijie Huaren Xiaohua Zazhi 2016; 24(4): 631-637 [DOI: 10.11569/wcjd.v24.i4.631] [Reference Citation Analysis]
25 Chen P, Tao L, Liu Z, Dong M, Jin R. Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B. FEBS J 2019;286:874-81. [PMID: 30347517 DOI: 10.1111/febs.14681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Fishbein SR, Robinson JI, Hink T, Reske KA, Newcomer EP, Burnham CD, Henderson JP, Dubberke ER, Dantas G. Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis. Elife 2022;11:e72801. [PMID: 35083969 DOI: 10.7554/eLife.72801] [Reference Citation Analysis]
27 Pan Z, Zhang Y, Luo J, Li D, Zhou Y, He L, Yang Q, Dong M, Tao L. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology. PLoS Pathog 2021;17:e1009197. [PMID: 33507919 DOI: 10.1371/journal.ppat.1009197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Shah HB, Smith K, Scott EJ 2nd, Larabee JL, James JA, Ballard JD, Lang ML. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight 2020;5:138137. [PMID: 32663199 DOI: 10.1172/jci.insight.138137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211020285. [PMID: 34104215 DOI: 10.1177/17562848211020285] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 von Schwartzenberg RJ, Bisanz JE, Lyalina S, Spanogiannopoulos P, Ang QY, Cai J, Dickmann S, Friedrich M, Liu SY, Collins SL, Ingebrigtsen D, Miller S, Turnbaugh JA, Patterson AD, Pollard KS, Mai K, Spranger J, Turnbaugh PJ. Caloric restriction disrupts the microbiota and colonization resistance. Nature 2021;595:272-7. [PMID: 34163067 DOI: 10.1038/s41586-021-03663-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
31 Jafari NV, Songane M, Stabler RA, Elawad M, Wren BW, Allan E, Bajaj-Elliott M. Host immunity to Clostridium difficile PCR ribotype 017 strains. Infect Immun 2014;82:4989-96. [PMID: 25225246 DOI: 10.1128/IAI.02605-14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
32 Kandalaft H, Hussack G, Aubry A, van Faassen H, Guan Y, Arbabi-Ghahroudi M, MacKenzie R, Logan SM, Tanha J. Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease. Appl Microbiol Biotechnol 2015;99:8549-62. [PMID: 25936376 DOI: 10.1007/s00253-015-6594-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
33 Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol 2016;14:609-20. [PMID: 27573580 DOI: 10.1038/nrmicro.2016.108] [Cited by in Crossref: 227] [Cited by in F6Publishing: 191] [Article Influence: 37.8] [Reference Citation Analysis]
34 Roxas BAP, Roxas JL, Claus-Walker R, Harishankar A, Mansoor A, Anwar F, Jillella S, Williams A, Lindsey J, Elliott SP, Shehab KW, Viswanathan VK, Vedantam G. Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes. Sci Rep 2020;10:22135. [PMID: 33335199 DOI: 10.1038/s41598-020-79123-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Murillo T, Ramírez-Vargas G, Riedel T, Overmann J, Andersen JM, Guzmán-Verri C, Chaves-Olarte E, Rodríguez C. Two Groups of Cocirculating, Epidemic Clostridiodes difficile Strains Microdiversify through Different Mechanisms. Genome Biol Evol 2018;10:982-98. [PMID: 29617810 DOI: 10.1093/gbe/evy059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
36 Tao L, Zhang J, Meraner P, Tovaglieri A, Wu X, Gerhard R, Zhang X, Stallcup WB, Miao J, He X, Hurdle JG, Breault DT, Brass AL, Dong M. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 2016;538:350-5. [PMID: 27680706 DOI: 10.1038/nature19799] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 22.0] [Reference Citation Analysis]
37 Pope RL, Chitrakar A, Sah P, Shadid T, Ballard JD, Zenewicz LA. Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes. Infect Immun 2022;:e0007322. [PMID: 35377172 DOI: 10.1128/iai.00073-22] [Reference Citation Analysis]
38 Fettucciari K, Marconi P, Marchegiani A, Fruganti A, Spaterna A, Bassotti G. Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficile. Therap Adv Gastroenterol 2021;14:17562848211032797. [PMID: 34413901 DOI: 10.1177/17562848211032797] [Reference Citation Analysis]
39 Stroke IL, Letourneau JJ, Miller TE, Xu Y, Pechik I, Savoly DR, Ma L, Sturzenbecker LJ, Sabalski J, Stein PD, Webb ML, Hilbert DW. Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity. Antimicrob Agents Chemother 2018;62:e00107-18. [PMID: 29483125 DOI: 10.1128/AAC.00107-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
40 Sehgal K, Khanna S. Immune response against Clostridioides difficile and translation to therapy. Therap Adv Gastroenterol 2021;14:17562848211014817. [PMID: 33995585 DOI: 10.1177/17562848211014817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Elahi M, Nakayama-Imaohji H, Hashimoto M, Tada A, Yamasaki H, Nagao T, Kuwahara T. The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis. Antibiotics (Basel) 2021;10:187. [PMID: 33671889 DOI: 10.3390/antibiotics10020187] [Reference Citation Analysis]
42 Winston JA, Rivera AJ, Cai J, Thanissery R, Montgomery SA, Patterson AD, Theriot CM. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids. Infect Immun 2020;88:e00045-20. [PMID: 32205405 DOI: 10.1128/IAI.00045-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
43 Baldan R, Trovato A, Bianchini V, Biancardi A, Cichero P, Mazzotti M, Nizzero P, Moro M, Ossi C, Scarpellini P, Cirillo DM. Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype. J Clin Microbiol 2015;53:2575-80. [PMID: 26041894 DOI: 10.1128/JCM.00533-15] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
44 Jassem AN, Prystajecky N, Marra F, Kibsey P, Tan K, Umlandt P, Janz L, Champagne S, Gamage B, Golding GR, Mulvey MR, Henry B, Hoang LM. Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region. Can J Infect Dis Med Microbiol 2016;2016:8207418. [PMID: 27366181 DOI: 10.1155/2016/8207418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
45 Welner D, Dedic E, van Leeuwen HC, Kuijper E, Bjerrum MJ, Østergaard O, Jørgensen R. Protein expression, characterization, crystallization and preliminary X-ray crystallographic analysis of a Fic protein from Clostridium difficile. Acta Crystallogr F Struct Biol Commun 2014;70:827-31. [PMID: 24915103 DOI: 10.1107/S2053230X1400987X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Ciftci Y, Girinathan BP, Dhungel BA, Hasan MK, Govind R. Clostridioides difficile SinR' regulates toxin, sporulation and motility through protein-protein interaction with SinR. Anaerobe 2019;59:1-7. [PMID: 31077800 DOI: 10.1016/j.anaerobe.2019.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Humphries RM, Linscott AJ. Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis. Clin Microbiol Rev 2015;28:3-31. [PMID: 25567220 DOI: 10.1128/CMR.00073-14] [Cited by in Crossref: 91] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]